top of page
DeepLife

Supported projects

DeepLife

Develops a SaaS platform combining generative AI and multi-omics data to create digital twins of cells, accelerating cellular engineering and drug discovery. Using deep learning algorithms, this technology enables in silico simulations to identify new therapeutic targets. A current project focuses on brain stem infiltrating glioma (BSIG), a rare paediatric cancer.

DeepLife
linkedin

PSCC's entrance

November 2024

Localization

FR - Île-de-France

Modality

TechBio

Development status

Medtech - Development

Award(s)

bottom of page